Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 3
1988 2
1989 2
1990 3
1991 7
1992 7
1993 1
1995 3
1996 1
1997 6
1998 1
1999 4
2000 1
2001 1
2002 3
2003 1
2004 2
2005 1
2006 2
2007 3
2008 2
2009 4
2010 3
2011 9
2012 6
2013 13
2014 7
2015 2
2016 11
2017 8
2018 3
2019 2
2020 6
2021 4
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

133 results
Results by year
Filters applied: . Clear all
Page 1
Nanobody-based cancer therapy of solid tumors.
Kijanka M, Dorresteijn B, Oliveira S, van Bergen en Henegouwen PM. Kijanka M, et al. Among authors: van bergen en henegouwen pm. Nanomedicine (Lond). 2015 Jan;10(1):161-74. doi: 10.2217/nnm.14.178. Nanomedicine (Lond). 2015. PMID: 25597775 Free article. Review.
Nanobodies in therapeutic applications.
Roovers RC, van Dongen GA, van Bergen en Henegouwen PM. Roovers RC, et al. Among authors: van bergen en henegouwen pm. Curr Opin Mol Ther. 2007 Aug;9(4):327-35. Curr Opin Mol Ther. 2007. PMID: 17694445 Review.
MAGE-A antigens as targets for cancer immunotherapy.
Schooten E, Di Maggio A, van Bergen En Henegouwen PMP, Kijanka MM. Schooten E, et al. Among authors: van bergen en henegouwen pmp. Cancer Treat Rev. 2018 Jun;67:54-62. doi: 10.1016/j.ctrv.2018.04.009. Epub 2018 Apr 26. Cancer Treat Rev. 2018. PMID: 29763778 Review.
Bispecific antibody platforms for cancer immunotherapy.
Lameris R, de Bruin RC, Schneiders FL, van Bergen en Henegouwen PM, Verheul HM, de Gruijl TD, van der Vliet HJ. Lameris R, et al. Among authors: van bergen en henegouwen pm. Crit Rev Oncol Hematol. 2014 Dec;92(3):153-65. doi: 10.1016/j.critrevonc.2014.08.003. Epub 2014 Aug 20. Crit Rev Oncol Hematol. 2014. PMID: 25195094 Review.
Targeting tumors with nanobodies for cancer imaging and therapy.
Oliveira S, Heukers R, Sornkom J, Kok RJ, van Bergen En Henegouwen PM. Oliveira S, et al. Among authors: van bergen en henegouwen pm. J Control Release. 2013 Dec 28;172(3):607-17. doi: 10.1016/j.jconrel.2013.08.298. Epub 2013 Sep 11. J Control Release. 2013. PMID: 24035975 Review.
Site-specific functionality and tryptophan mimicry of lipidation in tetraspanin CD9.
Neviani V, van Deventer S, Wörner TP, Xenaki KT, van de Waterbeemd M, Rodenburg RNP, Wortel IMN, Kuiper JK, Huisman S, Granneman J, van Bergen En Henegouwen PMP, Heck AJR, van Spriel AB, Gros P. Neviani V, et al. Among authors: van bergen en henegouwen pmp. FEBS J. 2020 Dec;287(24):5323-5344. doi: 10.1111/febs.15295. Epub 2020 Apr 7. FEBS J. 2020. PMID: 32181977 Free PMC article.
Homo-FRET imaging as a tool to quantify protein and lipid clustering.
Bader AN, Hoetzl S, Hofman EG, Voortman J, van Bergen en Henegouwen PM, van Meer G, Gerritsen HC. Bader AN, et al. Among authors: van bergen en henegouwen pm. Chemphyschem. 2011 Feb 25;12(3):475-83. doi: 10.1002/cphc.201000801. Epub 2010 Dec 22. Chemphyschem. 2011. PMID: 21344588 Free article. Review.
Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR.
Compte M, Harwood SL, Martínez-Torrecuadrada J, Perez-Chacon G, González-García P, Tapia-Galisteo A, Van Bergen En Henegouwen PMP, Sánchez A, Fabregat I, Sanz L, Zapata JM, Alvarez-Vallina L. Compte M, et al. Among authors: van bergen en henegouwen pmp. Front Immunol. 2021 Jan 7;11:614363. doi: 10.3389/fimmu.2020.614363. eCollection 2020. Front Immunol. 2021. PMID: 33488625 Free PMC article.
133 results